Xbrane Biopharma
0,298 SEK +2,76%2 investorer følger denne virksomhed
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Omsætning
238,73 mio.
EBIT %
-134,95 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
XBRANE
Daglig lav / høj pris
0,286 / 0,305
SEK
Markedsværdi
455,79 mio. SEK
Aktieomsætning
2,21 mio. SEK
Volumen
7,5 mio.
Seneste videoer
Finanskalender
Generalforsamling
02.05.2024
Delårsrapport
16.05.2024
Delårsrapport
17.07.2024
Delårsrapport
24.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ashkan Pouya | 11,0 % | 11,0 % |
Bengt Göran Westman | 8,3 % | 8,3 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Xbrane resolves on a directed issue of shares to guarantors in connection with the completed rights issue
Xbrane announces the outcome of the rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools